Sairopa B.V.
PrivateLast Round
VC Round
Apr 2, 2021
Est. Valuation
$34.86M
Company Overview
Sairopa B.V. is a clinical-stage biotechnology company that develops novel cancer immunotherapies by modulating the patient's immune system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sairopa B.V. Comparables
Compare Sairopa B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elpiscience Biopharmaceuticals | 78% | |
| OSE Immunotherapeutics | 78% | |
| ALX Oncology | 74% | |
Sairopa B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 2, 2021 |
Key People
Founding team and executive leadership
Sairopa B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Van Herk Group | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 245% MoM.
- Jan 13, 2024
Grew 25% QoQ, from 12 to 15 employees.
Sairopa B.V. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sairopa B.V.'s valuation, stock price, and market status.